Possible mechanisms relating diet and risk of colon cancer.

Two recent developments in cancer epidemiology and experimental carcinogenesis provide the basis for two possible mechanisms relating diet and colon cancer risk. The first development is the accumulating epidemiological evidence for an association between insulin resistance and colonic adenomas and cancers. This evidence suggests the following mechanism: the consumption of excess dietary energy results in the development of insulin resistance with increased circulating levels of insulin, triglycerides, and non-esterified fatty acids. These circulating factors subject colonic epithelial cells to a proliferative stimulus and also expose them to reactive oxygen intermediates. These long-term exposures result in the promotion of colon cancer. The second development is the continuing identification of agents that significantly inhibit experimental colon carcinogenesis. These observations suggest the following mechanism: focal loss of epithelial barrier function resulting from a failure of terminal differentiation results in the "leak" of a presently undefined toxin and a focal inflammatory response characterized by evidence of the activation of the COX-2 enzyme and an oxidative stress with the release of reactive oxygen intermediates. The resulting focal proliferation and mutagenesis give rise to aberrant crypt foci and adenomas. The process is inhibited by: (a) demulcents confined to the colonic lumen that "repair" the surface; (b) anti-inflammatory agents; or (c) antioxidants. The two mechanisms, i.e., insulin resistance acting throughout the body and focal epithelial barrier failure acting locally, can describe most of the known relationships between diet and colon cancer risk.

[1]  F. Bornet,et al.  Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. , 1999, The Journal of nutrition.

[2]  N. Yorioka,et al.  Effect of lipoproteins on cultured human mesangial cells. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  John D. Potter,et al.  Food, nutrition and the prevention of cancer : a global perspective , 2001 .

[4]  Evaluation of the potential for olestra to affect the availability of dietary phytochemicals. , 1997, The Journal of nutrition.

[5]  A. Kato,et al.  High expression of cyclooxygenase‐2 in macrophages of human colonic adenoma , 1999, International journal of cancer.

[6]  A. Hara,et al.  Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. , 1997, Carcinogenesis.

[7]  A. Merrill,et al.  Importance of sphingolipids and inhibitors of sphingolipid metabolism as components of animal diets. , 1997, The Journal of nutrition.

[8]  F. Macrae Fat and calories in colon and breast cancer: from animal studies to controlled clinical trials. , 1993, Preventive medicine.

[9]  Christopher D. Heinen,et al.  Microsatellite instability in aberrant crypt foci from human colons. , 1996, Cancer research.

[10]  A. El-Sohemy,et al.  Dietary cholesterol inhibits the development of aberrant crypt foci in the colon. , 1996, Nutrition and cancer.

[11]  C. L. Bird,et al.  Serum lipids and adenomas of the left colon and rectum. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[12]  B. Burton-Freeman Dietary fiber and energy regulation. , 2000, The Journal of nutrition.

[13]  B. Wilson,et al.  Light-induced fluorescence endoscopy of the gastrointestinal tract. , 2000, Gastrointestinal endoscopy clinics of North America.

[14]  J. Morrow,et al.  Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells. , 1999, Cancer research.

[15]  J Teissié,et al.  Time courses of mammalian cell electropermeabilization observed by millisecond imaging of membrane property changes during the pulse. , 1999, Biophysical journal.

[16]  H. Lynch,et al.  Morphological and morphometric measurements in colorectal mucosa of subjects at increased risk for colonic neoplasia. , 1993, Cancer letters.

[17]  J. Morrow,et al.  Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. , 1998, Cancer research.

[18]  R. Gibson,et al.  Dietary polyunsaturated fatty acids and inflammatory mediator production. , 2000, The American journal of clinical nutrition.

[19]  J. Scholefield,et al.  Faecal calprotectin levels in a high risk population for colorectal neoplasia , 2000, Gut.

[20]  T A Colacchio,et al.  A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. , 1994, The New England journal of medicine.

[21]  L. Lissner,et al.  Weight loss on a low-fat diet: consequence of the imprecision of the control of food intake in humans. , 1991, The American journal of clinical nutrition.

[22]  H. Palmer,et al.  Reactive oxygen species and antioxidants in signal transduction and gene expression. , 2009, Nutrition reviews.

[23]  H. Murai,et al.  Chemopreventive effects of ferulic acid on oral and rice germ on large bowel carcinogenesis. , 1999, Anticancer research.

[24]  W. R. Bruce,et al.  Recent hypotheses for the origin of colon cancer. , 1987, Cancer research.

[25]  A. Medline,et al.  Toxicity of orally administered fat to the colonic epithelium of mice. , 1985, Carcinogenesis.

[26]  C. Christoffersen,et al.  Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor , 1997, Diabetologia.

[27]  J. Potter,et al.  Colon cancer: a review of the epidemiology. , 1993, Epidemiologic reviews.

[28]  S. Bingham,et al.  Effect of meat and resistant starch on fecal excretion of apparent N-nitroso compounds and ammonia from the human large bowel. , 1997, Nutrition and cancer.

[29]  A. Medline,et al.  Insulin promotion of colon tumors in rats. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  S. Loft,et al.  Cancer risk and oxidative DNA damage in man , 1997, Journal of Molecular Medicine.

[31]  G. Corner,et al.  Evidence for genomic instability in human colonic aberrant crypt foci. , 1996, Oncogene.

[32]  R. Richart,et al.  Comparative electron-microscopic features of normal, hyperplastic, and adenomatous human colonic epithelium. II. Variations in surface architecture found by scanning electron microscopy. , 1973, Gastroenterology.

[33]  J. Weissfeld,et al.  Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. , 2000, The New England journal of medicine.

[34]  J. Cadet,et al.  Dextran sulfate enhances the level of an oxidative DNA damage biomarker, 8-oxo-7,8-dihydro-2'-deoxyguanosine, in rat colonic mucosa. , 1998, Cancer letters.

[35]  P. Mcneil,et al.  Gastrointestinal cell plasma membrane wounding and resealing in vivo. , 1989, Gastroenterology.

[36]  A. E. Rogers,et al.  Methyl donors in the diet and responses to chemical carcinogens. , 1995, The American journal of clinical nutrition.

[37]  S. Minkin,et al.  Aberrant crypt focus promotion and glucose intolerance: correlation in the rat across diets differing in fat, n-3 fatty acids and energy. , 1998, Carcinogenesis.

[38]  M. Gleave,et al.  Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides. , 2000, Journal of the National Cancer Institute.

[39]  C. Potten,et al.  Stem cells: the intestinal stem cell as a paradigm. , 2000, Carcinogenesis.

[40]  Brian C. Wilson,et al.  Recent Advances in Light‐Induced Fluorescence Endoscopy (LIFE) of the Gastrointestinal Tract , 1999 .

[41]  D. Corpet,et al.  Insulin injections promote the growth of aberrant crypt foci in the colon of rats. , 1997, Nutrition and cancer.

[42]  I. Talbot,et al.  Early expression of cyclo‐oxygenase‐2 during sporadic colorectal carcinogenesis , 1999, The Journal of pathology.

[43]  O. Vinogradova,et al.  Structural characterization and immunochemical detection of a fluorophore derived from 4-hydroxy-2-nonenal and lysine. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  G. Kelloff,et al.  Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. , 1987, Cancer research.

[45]  A. Sundset,et al.  Granulocyte marker protein is increased in stools from rats with azoxymethane-induced colon cancer. , 1999, Scandinavian journal of gastroenterology.

[46]  L. Roncucci,et al.  Cell kinetic evaluation of human colonic aberrant crypts. (Colorectal Cancer Study Group of the University of Modena and the Health Care District 16, Modena, Italy). , 1993, Cancer research.

[47]  G. Parnaud,et al.  Polyethylene-glycol, a potent suppressor of azoxymethane-induced colonic aberrant crypt foci in rats. , 1999, Carcinogenesis.

[48]  R. DeFronzo,et al.  Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.

[49]  R. Miller,et al.  Increased tight junctional permeability is associated with the development of colon cancer. , 1999, Carcinogenesis.

[50]  A. Hara,et al.  Suppression of azoxymethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls astaxanthin and canthaxanthin during the postinitiation phase. , 1995, Carcinogenesis.

[51]  K. Seibert,et al.  Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. , 1998, Cancer research.

[52]  L. Roncucci,et al.  Scanning electron microscopy of aberrant crypt foci in human colorectal mucosa. , 1998, Anticancer research.

[53]  M. Eastwood Interaction of dietary antioxidants in vivo: how fruit and vegetables prevent disease? , 1999, QJM : monthly journal of the Association of Physicians.

[54]  A. Baron,et al.  Effects of free fatty acids and ketone bodies on in vivo non-insulin-mediated glucose utilization and production in humans. , 1989, Metabolism: clinical and experimental.

[55]  D. Alberts,et al.  Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. , 2000, The New England journal of medicine.

[56]  I. Rowland,et al.  Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. , 1998, Carcinogenesis.

[57]  W. J. Visek,et al.  Dietary fats and health , 1985 .

[58]  A. Whittemore,et al.  Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. , 1992, Journal of the National Cancer Institute.

[59]  A. Renehan,et al.  Response: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3 , 1999 .

[60]  J. Magnen Regulation of Food Intake , 1972 .

[61]  J. Mazuski,et al.  The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis. , 1999, The Journal of surgical research.

[62]  H. Schjønsby,et al.  Improved assay for fecal calprotectin. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[63]  M. Prentki,et al.  Are the β-Cell Signaling Molecules Malonyl-CoA and Cystolic Long-Chain Acyl-CoA Implicated in Multiple Tissue Defects of Obesity and NIDDM? , 1996, Diabetes.

[64]  J. Mandel,et al.  N-acetylcysteine suppression of the proliferative index in the colon of patients with previous adenomatous colonic polyps. , 1999, Cancer letters.

[65]  Bruce Wr Recent hypotheses for the origin of colon cancer. , 1987 .

[66]  L Bravo,et al.  Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. , 2009, Nutrition reviews.

[67]  T. Wilkins,et al.  The Bacteroides fragilis toxin fragilysin disrupts the paracellular barrier of epithelial cells , 1997, Infection and immunity.

[68]  R. Shields,et al.  Absorption and secretion of electrolytes and water by the human colon, with particular reference to benign adenoma and papilloma , 1966, The British journal of surgery.

[69]  Stampfer,et al.  Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. , 1999, Journal of the National Cancer Institute.

[70]  E. Riboli,et al.  Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. , 2000, Journal of the National Cancer Institute.

[71]  S. Bingham,et al.  Dietary fibre, fermentation and large bowel cancer. , 1987, Cancer surveys.

[72]  S. Minkin,et al.  Diet, aberrant crypt foci and colorectal cancer. , 1993, Mutation research.

[73]  P. Marteau,et al.  Inability of Lactobacillus casei strain GG, L. acidophilus, and Bifidobacterium bifidum to degrade intestinal mucus glycoproteins. , 1995, Scandinavian journal of gastroenterology.

[74]  J. Cummings,et al.  The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis , 2000, Gut.

[75]  T. Wolever,et al.  Mechanisms Linking Diet and Colorectal Cancer: The Possible Role of Insulin Resistance , 2000, Nutrition and cancer.

[76]  M. Wargovich,et al.  Inhibition of aberrant crypt foci by chemopreventive agents. , 1998, In vivo.

[77]  A. D. Jong Regulation of food intake in the goat , 1981 .

[78]  J. Potter,et al.  Colorectal cancer: molecules and populations. , 1999, Journal of the National Cancer Institute.

[79]  J. Alexander,et al.  A fish oil-derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl esters inhibits the formation and growth of aberrant crypt foci in rat colon. , 1998, Pharmacology & toxicology.

[80]  G. Bi,et al.  The mechanism of facilitated cell membrane resealing. , 1999, Journal of cell science.

[81]  M. C. Archer,et al.  Sucrose enhancement of the early steps of colon carcinogenesis in mice. , 1993, Carcinogenesis.

[82]  L. Rossetti,et al.  Mechanisms of fatty acid-induced inhibition of glucose uptake. , 1994, The Journal of clinical investigation.

[83]  D. Brassart,et al.  Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. , 1994, Gut.

[84]  H. Kashihara,et al.  Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ. , 1998, International journal of epidemiology.

[85]  K. Sekine,et al.  Influence of ethyl 3-(4'-geranyloxy-3'-methoxyphenyl)-2-propenoate (EGMP) on early stage colon carcinogenesis in rats treated with azoxymethane (AOM). , 1999, Anticancer research.

[86]  R. F. Parker,et al.  Effect of Pluronic F68 on Growth of Fibroblasts in Suspension on Rotary Shaker , 1960, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[87]  T. Wolever,et al.  Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high-fat diet. , 1997, Nutrition and cancer.

[88]  A. Drewnowski,et al.  Energy density, palatability, and satiety: implications for weight control. , 2009, Nutrition reviews.

[89]  W C Willett,et al.  The causes and prevention of cancer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[90]  S. Baba,et al.  Piroxicam and Acarbose as Chemopreventive Agents for Spontaneous Intestinal Adenomas in APC Gene 1309 Knockout Mice , 1998, Japanese journal of cancer research : Gann.

[91]  M. Brownlee,et al.  Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. , 1990, Biochemical and biophysical research communications.

[92]  J. Van Loo,et al.  On the presence of inulin and oligofructose as natural ingredients in the western diet. , 1995, Critical reviews in food science and nutrition.

[93]  C. Davis,et al.  Protection by chlorophyllin and indole-3-carbinol against 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced DNA adducts and colonic aberrant crypts in the F344 rat. , 1995, Carcinogenesis.

[94]  J. L. Greger,et al.  Lipid absorption and intestinal tumour incidence in rats fed on varying levels of calcium and butterfat , 1990, British Journal of Nutrition.

[95]  S. Ritland,et al.  Chemoprevention of intestinal adenomas in the ApcMin mouse by piroxicam: kinetics, strain effects and resistance to chemosuppression. , 1999, Carcinogenesis.

[96]  J Teissié,et al.  The generation of reactive-oxygen species associated with long-lasting pulse-induced electropermeabilisation of mammalian cells is based on a non-destructive alteration of the plasma membrane. , 1999, Biochimica et biophysica acta.

[97]  I. Siu,et al.  Identification of dysplasia in human colonic aberrant crypt foci. , 1997, The American journal of pathology.

[98]  G. McKeown-Eyssen Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[99]  G A Colditz,et al.  Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. , 1999, Journal of the National Cancer Institute.

[100]  A. Hara,et al.  Chemoprevention of azoxymethane-induced colon carcinogenesis by dietary feeding of S-methyl methane thiosulfonate in male F344 rats. , 1995, Cancer research.

[101]  M. Knize,et al.  Occurrence, identification, and bacterial mutagenicity of heterocyclic amines in cooked food. , 1991, Mutation research.

[102]  D. Dardevet,et al.  Lipid peroxidation and antioxidant status in experimental diabetes. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[103]  E. Calle,et al.  Colorectal cancer: another complication of diabetes mellitus? , 1998, American journal of epidemiology.

[104]  P. Dolara,et al.  Intercellular communication in normal and aberrant crypts of rat colon mucosa. , 1998, Cancer letters.

[105]  L H Kuller,et al.  Increased blood glucose and insulin, body size, and incident colorectal cancer. , 1999, Journal of the National Cancer Institute.

[106]  K. Overvad,et al.  Effect of exercise on intestinal tumour development in the male Fischer rat after exposure to azoxymethane. , 1993, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[107]  O. Børmer,et al.  Fecal calprotectin concentration in patients with colorectal carcinoma , 1998, Diseases of the colon and rectum.

[108]  C. Bonifer,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1998.0224 Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice , 2022 .

[109]  E. Ferrannini,et al.  Insulin decreases circulating vitamin E levels in humans. , 1996, Metabolism: clinical and experimental.

[110]  Y. Doki,et al.  Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.